Cargando…
Synergistic effect of combining sunitinib with a peptide-based vaccine in cancer treatment after microenvironment remodeling
Although it has proven difficult to demonstrate the clinical efficacy of therapeutic vaccination as a monotherapy in advanced cancers, its combination with an immunomodulatory treatment to reduce intra-tumor immunosuppression and improve vaccine efficacy is a very promising strategy. In this context...
Autores principales: | Mougel, Alice, Méjean, Fanny, Tran, Thi, Adimi, Yasmine, Galy-Fauroux, Isabelle, Kaboré, Christelle, Mercier, Erwan, Urquia, Pauline, Terme, Magali, Tartour, Eric, Tanchot, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367646/ https://www.ncbi.nlm.nih.gov/pubmed/35968405 http://dx.doi.org/10.1080/2162402X.2022.2110218 |
Ejemplares similares
-
Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
por: Mougel, Alice, et al.
Publicado: (2019) -
Modulation of Immunity by Antiangiogenic Molecules in Cancer
por: Terme, Magali, et al.
Publicado: (2012) -
Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment
por: Bourhis, Morgane, et al.
Publicado: (2021) -
High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4(+) and CD8(+) T-Cell Epitopes
por: Onodi, Fanny, et al.
Publicado: (2018) -
VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer
por: Terme, Magali, et al.
Publicado: (2013)